Literature DB >> 16784889

Malaria tolerance--for whom the cell tolls?

Craig S Boutlis1, Tsin W Yeo, Nicholas M Anstey.   

Abstract

How is it that individuals exposed to intense malaria transmission can tolerate the presence of malaria parasites in their blood at levels that would produce fever in others? In light of evidence discounting a role for nitric oxide or antibodies to plasmodial glycosylphosphatidylinositols in maintaining this tolerant state, refractoriness to toxin-induced Toll-like receptor-mediated signalling has emerged as a likely explanation that links malarial and bacterial endotoxin tolerance. Understanding the mechanisms underlying tolerance and the potential for cross-tolerization has significant implications for understanding the potential for antitoxic vaccine strategies, as well as interactions between different malaria species and between malaria and other human parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784889      PMCID: PMC2766419          DOI: 10.1016/j.pt.2006.06.002

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  80 in total

Review 1.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

Review 2.  Immunological processes in malaria pathogenesis.

Authors:  Louis Schofield; Georges E Grau
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

Review 3.  Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors.

Authors:  T Nebl; M J De Veer; L Schofield
Journal:  Parasitology       Date:  2005       Impact factor: 3.234

4.  Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children.

Authors:  N M Anstey; J B Weinberg; Z Wang; E D Mwaikambo; P E Duffy; D L Granger
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

5.  Synergy between TLR2 and TLR4: a safety mechanism.

Authors:  E Beutler; T Gelbart; C West
Journal:  Blood Cells Mol Dis       Date:  2001 Jul-Aug       Impact factor: 3.039

6.  Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia.

Authors:  Craig S Boutlis; J Brice Weinberg; Joanne Baker; Moses J Bockarie; Charles S Mgone; Qin Cheng; Nicholas M Anstey
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 8.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

Review 9.  The pathophysiology of falciparum malaria.

Authors:  Ian A Clark; William B Cowden
Journal:  Pharmacol Ther       Date:  2003-08       Impact factor: 12.310

10.  Inducible nitric oxide synthase is not required in the development of endotoxin tolerance in mice.

Authors:  Basilia Zingarelli; Paul W Hake; James A Cook
Journal:  Shock       Date:  2002-06       Impact factor: 3.454

View more
  41 in total

Review 1.  Malarial fever: hemozoin is involved but Toll-free.

Authors:  Ralf R Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-01       Impact factor: 11.205

Review 2.  Decomposing health: tolerance and resistance to parasites in animals.

Authors:  Lars Råberg; Andrea L Graham; Andrew F Read
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

3.  Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Authors:  Steven Kho; Jutta Marfurt; Rintis Noviyanti; Andreas Kusuma; Kim A Piera; Faustina H Burdam; Enny Kenangalem; Daniel A Lampah; Christian R Engwerda; Jeanne R Poespoprodjo; Ric N Price; Nicholas M Anstey; Gabriela Minigo; Tonia Woodberry
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

4.  Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.

Authors:  Bernardo S Franklin; Peggy Parroche; Marco Antonio Ataíde; Fanny Lauw; Catherine Ropert; Rosane B de Oliveira; Dhelio Pereira; Mauro Shugiro Tada; Paulo Nogueira; Luiz Hildebrando Pereira da Silva; Harry Bjorkbacka; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 5.  Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Authors:  Silvia Portugal; Susan K Pierce; Peter D Crompton
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

6.  Differential gene expression mediated by 15-hydroxyeicosatetraenoic acid in LPS-stimulated RAW 264.7 cells.

Authors:  Alexandra C Schrimpe; David W Wright
Journal:  Malar J       Date:  2009-08-11       Impact factor: 2.979

Review 7.  Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases.

Authors:  David S Schneider; Janelle S Ayres
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

8.  Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells.

Authors:  Kurt A Wong; Ana Rodriguez
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

9.  Animal defenses against infectious agents: is damage control more important than pathogen control.

Authors:  Andrew F Read; Andrea L Graham; Lars Råberg
Journal:  PLoS Biol       Date:  2008-12-23       Impact factor: 8.029

10.  Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection.

Authors:  Ivo Müller; Blaise Genton; Lawrence Rare; Benson Kiniboro; Will Kastens; Peter Zimmerman; James Kazura; Michael Alpers; Thomas A Smith
Journal:  Malar J       Date:  2009-07-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.